Chemotherapy Drugs Flashcards

1
Q

What are the two classes of alkylating agent?

A

Nitrogen Mustards
Platinum Analogs

(Also: nitrosoureas and alkylsulfonates, but these weren’t discussed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of Alkylating Agents?

A

Alkylate DNA at N7 position of guanine…leads to protein miscoding and apoptosis

Can also cause cross-linking of DNA…damaged DNA cannot repair and undergoes apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical indications of Cyclophosphamide

A
Lymphomas
Leukemias
Multiple Myeloma
Breast and Ovarian Carcinoma
Small Cell Lung Cancer
Some Autoimmune Conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What prevents hemorrhagic cystitis that is a side effect of cyclophosphamide?

A

MESNA: mecaptoethane sulfonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical Indications of Cisplatin

A

Testicular, Ovarian, Bladder, Non-Small and Small Cell Lung Cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cisplatin has prominent activity during which phase of the cell cycle?

A

S phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Toxicities of Cisplatin

A
  • Dose-limiting toxicity is cumulateive, leading to irreversible damage to the renal tubules (prevented with mannitol)
  • Ototoxic with tinnitus, hearing loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Resistance of Alkylating Agents

A
  • Increased DNA repair ability of the tumor cells
  • Decreased transport of alkylating drug into cell
  • Increased production of glutathione and glutathione-associated proteins
  • Increased glutathione S-transferase activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the three subclasses of antimetabolites?

A

Folic Acid Analogs
Purine Analogs
Pyrimidine Analogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does Methotrexate work?

A

Folic acid analog that binds to the active site of DHFR

Blocks the formation of THF, resulting in interruption in DNA, RNA, and protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Renal excretion of MTX is inhibited when it interacts with…

A

Penicillin
Cephalosporins
NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug is used in combo with MTX as a rescue drug?

A

Leucovorin: rescues normal cells from toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

6-MP and 6-TG are metabolized by ____ to active metabolites ____ and ____

A

HGPRT
TIMP
TGMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical Uses of 6-MP and 6-TG

A

6-MP: ALL, AML, Crohn’s

6-TG: AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The purpose of allopurinol with 6-MP use

A

Prevents hyperuricemia by inhibiting 6-MP metabolism by xanthine oxidace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of Action of 5-FU

A

5-FU gets converted to 5-FUTP, 5-FdUMP, 5-FdUTP

5-FUMP –> RNA damage
5-FdUMP –> DNA damage and inhibits thymidylate synthase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Uses for 5-FU

A

Colon cancer (5-FdUMP), breast, gastroesophageal, hepatocellular, pancreatic cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA of vinca alkaloids

A

Binds to B-tubulin and prevents polymerization

Depolymerization of microtubules blocking mitotic spindle formation during M phase

Mitotic arrest at metaphase interferes with chromosome segregation

19
Q

Vinblastine: Indications

A

Hodgkin’s, non-Hodgkin’s
Breast Cancer
Testicular Tumors

20
Q

Vinblastine Toxicity

A

Bone marrow suppression, anorexia, N/V/D, alopecia

21
Q

Vincristine: Indications

A

Childhood Cancer, Childhood Tumors

22
Q

Vincristine: Toxicities

A

Peripheral neuritis/neuropathy with paresthesia, muscle weakness

MARROW SPARING

23
Q

Etoposide, Teniposide: Indications

A

Testicular, Non-small and small cell lung carcinomas, AML, ALL, Hodgkin’s and non-Hodgkin’s

24
Q

Etoposide, Teniposide: MOA

A

Blocks tumor cells in the late S-G2 phase of cell cycle through inhibition of topoisomerase II

25
Topotecan and Irinotecan: Indications
Topotecan: Ovarian and small cell lung cancers Irinotecan: metastatic colon cancer
26
Camptothecins: MOA
Inhibit topoisomerase I resulting in DNA strand breakage
27
Doxorubicine: Indications
Hodgkin's and non-Hodgkin's, breast, ovarian, bladder cancers, ALL
28
Doxorubicin is derived from...
Streptomyces
29
Doxorubicine: MOA
Intercalation interferes with DNA synthesis | Inhibits topoisomerase II leading to DNA fragmentation
30
Doxorubicine: Toxicities
Reversible acute arrhythmias and conduction abnormalities
31
Bleomycin: Toxicities
Dose-limiting pulmonary fibrosis that can be fatal
32
Bleomycin: Indications
Testicular, squamous cell carcinoma, Hodgkin's and non-Hodgkin's
33
Bleomycin: MOA
Intercalation, scission, and fragmentation of DNA due to an oxidation reaction mediated by a DNA-bleomycin-Fe complex
34
Cancer Treatment Modalities
``` Surgery Radiotherapy Chemotherapy Endocrine Therapy MAB/Biologics Small Molecule Inhibitors ```
35
Log-Kill Hypothesis
Killing action of CCS (cell-cycle specific) drugs follows first order kinetics (a given dose kills a proportion of a cancer cell population
36
Most solid tumors display what type of pattern?
Gompertzian...growth rates decline as tumor expands
37
Dose-limiting toxicity
Each cytotoxic drug is associated with a particular organ that effectively limits the max dose of the drug that can be given to a patient
38
Types of Drug Resistance
1. Primary: tumor cells don't respond to initial chemotherapy 2. Acquired: develops as a consequence of chemotherapy
39
Examples of Drug Resistance
1. Up-regulation of drug resistance transporters 2. Down-regulation of methotrexate transporter 3. Increased expression of DNA repaired enzymes 4. Increased expression enzymes that produce trapping metabolites within resistant cells
40
CSC Theory to Resistance
Anti-cancer treatments can often shrink tumor size by targeting bulk but they fail to target and kill CSCs leading to treatment failure, relapse, and death
41
Properties of CSCs
Undergo asymmetric cell division: 1 CSC and 1 daughter cell Resistant to standard chemotherapy Resistant to radiation (linked to loss of suppressor gene p53)
42
Principles of Combination Chemotherapy Regimen
1. Drugs with different mechanism of action should be combined 2. Drugs targeting different populations of cancer cells should be combined CCS with CCNS drugs 3. Drugs with different organ toxicities should be combined, so full/nearly full therapeutic doses can be utilized for each drug 4. Drugs associated with different modes of resistance should be combined to minimize cross-resistance 5. Identify drug combinations that allow for the shortest possible treatment-free period
43
Rapidly growing tumors are most sensitive to...
CCS chemotherapeutic drugs
44
CCNS definition
Cell Cycle Non-Specific Drugs | Drugs capable of exerting their actions on cancer cells that are cycling or in the resting state